D Hauschke

Comment on: Updates of bioequivalence programs (including statistical power approximated by Student's t)

D Hauschke, D. Hauschke, 1995, Computer methods and programs in biomedicine.

Approximate sample sizes for testing hypotheses about the ratio and difference of two means.

M Kieser, D Hauschke, M. Kieser, 1999, Journal of biopharmaceutical statistics.

STAT3 expression, activity and functional consequences of STAT3 inhibition in esophageal squamous cell carcinomas and Barrett’s adenocarcinomas

D Hauschke, T. Reinheckel, M. Boerries, 2014, Oncogene.

Reference tables for the intrasubject coefficient of variation in bioequivalence studies.

D Hauschke, R. Schall, D. Hauschke, 1995, International journal of clinical pharmacology and therapeutics.

IDENTIFYING THE MAXIMUM SAFE DOSE: A MULTIPLE TESTING APPROACH

L A Hothorn, D Hauschke, L. Hothorn, 2000, Journal of biopharmaceutical statistics.

A distribution-free procedure for the statistical analysis of bioequivalence studies.

D Hauschke, D. Hauschke, V. Steinijans, 1990, International journal of clinical pharmacology, therapy, and toxicology.

Sample size determination for proving equivalence based on the ratio of two means for normally distributed data.

M Kieser, D Hauschke, M. Kieser, 1999, Statistics in medicine.

Individual bioequivalence--a European perspective.

D Hauschke, V W Steinijans, 1997, Journal of biopharmaceutical statistics.

Consensus and controversy in pharmaceutical statistics - Discussion

David J. Spiegelhalter, Anthony C. Atkinson, G. A. Barnard, 2000 .